Trial Profile
Phase I Clinical Trial to Determine the Maximum Tolerated Dose and to Assess the Safety and Pharmacokinetic Profile of Oral Paclitaxel in Patients With Advanced Solid Cancer
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Dec 2011
Price :
$35
*
At a glance
- Drugs HM 30181A (Primary) ; Paclitaxel (Primary)
- Indications Cancer
- Focus Adverse reactions
- 15 Dec 2011 New trial record